Jin Hong, Zhao Wei, Zhang Lili, Zheng Zhongqing, Wang Tao, Wu Lanlan, Wang Bangmao
Z Gastroenterol. 2018 Feb;56(2):111-116. doi: 10.1055/s-0043-120348. Epub 2017 Nov 7.
Peroral endoscopic myotomy (POEM), first introduced in 2010, appears to be an effective therapy with few complications. This study aimed to find an optimal predictor of POEM outcome in achalasia.
We retrospectively assessed 89 patients diagnosed with achalasia who underwent POEM in General Hospital of Tianjin Medical University, from September 2012 to March 2015. Associations of Eckardt score with symptom duration, lower esophageal resting pressure, 4-second integrated relaxation pressure (4s-IRP), and maximum esophageal diameter were assessed before POEM. The most relevant data were progressively grouped to compare symptom improvement after POEM in 85 patients at 1 year follow-up.
The most significant correlation was found between 4s-IRP and Eckardt score (p < 0.01). The 85 achalasia patients (1-year follow-up after POEM) were divided into 3 groups according to 4s-IRP values; patients with mean 4s-IRP of 25 - 34 mmHg exhibited significantly greater improvement of clinical symptoms compared with the remaining 2 groups (p < 0.05). No significant postoperative difference was noted between types I and II in all patients according to Chicago classification criteria. The 40 patients with 4s-IRP of 25 - 34 mmHg were further divided into 2 subgroups; the 28 patients with type II achalasia responded better to POEM than the 12 with type I disease (p < 0.05).
4s-IRP, together with achalasia subtypes, may predict treatment outcome after POEM. Patients with type II achalasia and 4s-IRP of 25 - 34 mmHg may experience more satisfactory remission after POEM.
经口内镜下肌切开术(POEM)于2010年首次引入,似乎是一种有效的治疗方法,并发症较少。本研究旨在寻找贲门失弛缓症患者POEM治疗效果的最佳预测指标。
我们回顾性评估了2012年9月至2015年3月在天津医科大学总医院接受POEM治疗的89例诊断为贲门失弛缓症的患者。在POEM治疗前,评估埃卡德特评分与症状持续时间、食管下括约肌静息压力、4秒综合松弛压力(4s-IRP)和食管最大直径之间的相关性。将最相关的数据逐步分组,以比较85例患者在POEM治疗后1年随访时的症状改善情况。
发现4s-IRP与埃卡德特评分之间存在最显著的相关性(p<0.01)。根据4s-IRP值,将85例贲门失弛缓症患者(POEM治疗后1年随访)分为3组;平均4s-IRP为25-34mmHg的患者与其余2组相比,临床症状改善明显更大(p<0.05)。根据芝加哥分类标准,所有患者中I型和II型在术后无显著差异。将4s-IRP为25-34mmHg的40例患者进一步分为2个亚组;28例II型贲门失弛缓症患者对POEM的反应比12例I型疾病患者更好(p<0.05)。
4s-IRP以及贲门失弛缓症亚型可能预测POEM治疗后的结果。II型贲门失弛缓症且4s-IRP为25-34mmHg的患者在POEM治疗后可能会有更满意的缓解。